Louis J. Aronne, M.D.

Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

Dr. Kimberly Sippel attended Harvard College in Cambridge, Massachusetts, graduating with honors in Biochemical Sciences. She received her medical degree with the Alpha Omega Alpha honor distinction from the Columbia University College of Physicians & Surgeons in New York City. Following two years of training in general surgery at the Massachusetts General Hospital, Dr. Sippel completed ophthalmology residency training at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. She then completed the fellowship program in Cornea and External Disease at the Massachusetts Eye and Ear Infirmary, and is a recipient of both a Heed Foundation fellowship, as well as the American Ophthalmological Society Knapp Foundation fellowship award. Dr. Sippel also pursued several years of vision-related laboratory investigation as a Research Fellow at both the Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston, Massachusetts. Dr. Sippel is a diplomate of the American Board of Ophthalmology. Dr. Sippel is an Assistant Professor of Ophthalmology at the Weill Cornell Medicine and the NewYork Presbyterian Hospital. Prior to joining the Weill Cornell faculty, Dr. Sippel was with Cornea Consultants of Boston/ Laser Eye Consultants of Boston and had an active teaching role at Massachusetts Eye & Ear Infirmary. Her interests include laser vision correction surgery, corneal transplantation and cataract surgery, corneal disease and dry eye, and conjunctival tumors.Kimberly C. Sippel, M.D. discusses the specifics of the cornea.

Donald J. D'Amico, MD, Professor and Chair of the Israel Englander Department of Ophthalmology at Weill Cornell Medical College and Ophthalmologist-in-Chief at the New York Presbyterian Hospital, is an internationally recognized leader in the field of vitreoretinal surgery. He assumed the Chair at Weill Cornell in 2006 after his longstanding positions at Harvard Medical School as Professor of Ophthalmology, and as Associate Chief of Ophthalmology and Director of the Diabetic Unit at the Massachusetts Eye and Ear Infirmary.A graduate of the Massachusetts Institute of Technology and the University of Illinois College of Medicine, he completed his residency at the Massachusetts Eye and Ear Infirmary. He completed his fellowship in vitreoretinal diseases at the Bascom Palmer Eye Institute, University of Miami, followed by selection as Chief Resident in Ophthalmology at the Massachusetts Eye and Ear Infirmary prior to joining the Harvard faculty.Dr. D'Amico has published over 175 articles on vitreoretinal diseases and has co-edited two books covering comprehensive retinal themes. He has participated as a principal investigator or co-investigator in many clinical trials and laboratory investigations. His major interests include: vitreoretinal surgery; diabetic retinopathy; macular degeneration; experimental lasers and other technologies for the surgical treatment of vitreoretinal disorders such as retinal detachment, macular holes and epiretinal membranes; and endophthalmitis and intravitreal drug therapy. As attending physician specializing in the care of patients with vitreoretinal disorders at the Israel Englander Department of Ophthalmology, Dr. D'Amico also provides direct instruction of medical students, ophthalmology residents, and retina fellows. In this role he has twice received the Teacher of the Year Award given by the residents of the Massachusetts Eye and Ear Infirmary.Dr. D'Amico is a distinguished national and international lecturer and is the recipient of many honors, including the Honor Award and the Senior Achievement Award from the American Academy of Ophthalmology. He serves on the board of four major journals, and is highly active in professional societies. He is a past President of the Retina Society, and is the immediate past President of the prestigious international retinal organization Club Jules Gonin. Donald J. D'Amico, M.D., Professor and Chair of the Israel Englander Department of Ophthalmology at Weill Cornell Medical College and Ophthalmologist-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center, discusses diabetic retinopathy, a retina disorder caused by complications of diabetes.